Company · Montreal, Quebec, Canada
Searchlight Pharma Inc.
Everything this company holds in Health Canada’s product databases, as the company’s name is spelled there.
- Drug products (DIN)
- 87
- 65 authorized now
- Natural health products
- 9
- 4 active licences
- Medical device licences
- 0
- 0 active
- Notices of Compliance
- 76
Drug products
Authorized products first.
| Name | DIN | Status | Status since |
|---|---|---|---|
| ADRENALIN | 00155357 | Marketed | |
| ADRENALIN TOPICAL SOLUTION | 00155365 | Marketed | |
| ANAPROX | 02162725 | Marketed | |
| ANAPROX DS | 02162717 | Marketed | |
| ATARAX | 00024694 | Marketed | |
| CEREBYX | 02230988 | Marketed | |
| CERUBIDINE | 01926683 | Marketed | |
| CHLOROMYCETIN SUCCINATE INJECTION | 00312363 | Marketed | |
| CHOLEDYL EXPECTORANT | 00476374 | Marketed | |
| COLY-MYCIN M | 00476420 | Marketed | |
| DIPENTUM | 02063808 | Marketed | |
| DIVIGEL | 02424835 | Marketed | |
| DIVIGEL | 02424843 | Marketed | |
| DIVIGEL | 02424924 | Marketed | |
| ENABLEX | 02273217 | Marketed | |
| ENABLEX | 02273225 | Marketed | |
| EPSOLAY | 02560720 | Marketed | |
| ERFA HYDROQUINONE | 02491702 | Marketed | |
| ESTRAGYN VAGINAL CREAM | 00727369 | Marketed | |
| EVRA | 02248297 | Marketed | |
| FAMVIR | 02177102 | Marketed | |
| FAMVIR | 02229110 | Marketed | |
| FAMVIR | 02229129 | Marketed | |
| HALOETTE | 02520028 | Marketed | |
| HUMATIN | 02078759 | Marketed | |
| KETALAR | 00224391 | Marketed | |
| KETALAR | 00224405 | Marketed | |
| LITHANE | 00406775 | Marketed | |
| LITHANE | 02013231 | Marketed | |
| NAPROSYN | 02162466 | Marketed | |
| NAPROSYN | 02162423 | Marketed | |
| NARDIL | 00476552 | Marketed | |
| NEULEPTIL | 01926772 | Marketed | |
| NEULEPTIL | 01926780 | Marketed | |
| NEULEPTIL | 01926756 | Marketed | |
| NEXTSTELLIS | 02513218 | Marketed | |
| NORLUTATE | 00023760 | Marketed | |
| PARSITAN 50 | 01927744 | Marketed | |
| PYRIDIUM | 00476714 | Marketed | |
| ROCALTROL | 00481815 | Marketed | |
| ROCALTROL | 00481823 | Marketed | |
| SOFRAMYCIN NASAL SPRAY | 02224860 | Marketed | |
| TENORMIN | 02039532 | Marketed | |
| TENORMIN | 02039540 | Marketed | |
| THYROID | 00023949 | Marketed | |
| THYROID | 00023957 | Marketed | |
| THYROID | 00023965 | Marketed | |
| VALIUM | 00013285 | Marketed | |
| VANCOCIN | 00788716 | Marketed | |
| VANCOCIN | 00800430 | Marketed | |
| ZARONTIN | 00022799 | Marketed | |
| ZARONTIN SYRUP | 00023485 | Marketed | |
| ZESTORETIC | 02103729 | Marketed | |
| ZESTORETIC | 02045737 | Marketed | |
| ZESTORETIC | 02045729 | Marketed | |
| ZESTRIL | 02049384 | Marketed | |
| ZESTRIL | 02049333 | Marketed | |
| ZESTRIL | 02049376 | Marketed | |
| ADRENALIN | 02562200 | Approved | |
| NEULEPTIL | 01926764 | Dormant | |
| PYRIDIUM | 00476722 | Dormant | |
| SOFRAMYCIN EYE DROPS | 02224887 | Dormant | |
| SOFRAMYCIN SKIN OINTMENT | 02224879 | Dormant | |
| SOFRAMYCIN STERILE EYE OINTMENT | 02224895 | Dormant | |
| TWYNEO | 02563487 | Approved | |
| AMSA PD | 00582212 | Cancelled Post Market | |
| ARLIDIN | 01926713 | Cancelled Post Market | |
| CHOLEDYL | 00476366 | Cancelled Post Market | |
| ERFA-AMIKACIN | 02489147 | Cancelled Post Market | |
| ERFA-TRANEXAMIC | 02457431 | Cancelled Post Market | |
| ESTRAGYN | 00287725 | Cancelled Post Market | |
| ESTRAGYN | 00473618 | Cancelled Post Market | |
| MAJEPTIL | 01927639 | Cancelled Post Market | |
| MANDELAMINE | 00499013 | Cancelled Post Market | |
| NAPROSYN | 02162415 | Cancelled Post Market | |
| NAVANE | 00024449 | Cancelled Post Market | |
| OESCLIM | 02243722 | Cancelled Post Market | |
| OESCLIM | 02243723 | Cancelled Post Market | |
| OESCLIM | 02243724 | Cancelled Post Market | |
| OESCLIM | 02243725 | Cancelled Post Market | |
| OESCLIM | 02243726 | Cancelled Post Market | |
| PANECTYL | 01926306 | Cancelled Post Market | |
| PANECTYL | 01926292 | Cancelled Post Market | |
| PREFESTA | 02247906 | Cancelled Pre Market | |
| PROCAN SR | 00638692 | Cancelled Post Market | |
| SOFRA-TULLE | 01988840 | Cancelled Post Market | |
| SOFRA-TULLE | 01987682 | Cancelled Post Market |
Natural health products
Active licences first, newest first.
| Name | NPN | Status | Licensed |
|---|---|---|---|
| Urolo-Q | 80039114 | Active | |
| Cysturol | 80038525 | Active | |
| Bacid | 80017987 | Active | |
| Bacid | 01927906 | Active | |
| Halykoo Vapour Night Pads with Essential Oils | 80071677 | Discontinued | |
| Halykoo fizzy probiotic powder | 80066982 | Discontinued | |
| HALYKOO Happy Travel Kids Lolly | 80066984 | Discontinued | |
| Halykoo Diaper Rash Spray with Zinc Oxide | 80066986 | Discontinued | |
| HALYKOO Multivitamin Choco Drops | 80066773 | Discontinued |
Notices of Compliance
Newest first.
- NEXTSTELLISSeptember 14, 2026 · NOC 38283 · Supplement to a New Drug Submission (SNDS)
- EVRAAugust 18, 2026 · NOC 38128 · Supplement to a New Drug Submission (SNDS)
- VANCOCINMay 12, 2026 · NOC 37524 · Supplement to a New Drug Submission (SNDS)
- NAPROSYNDecember 16, 2025 · NOC 36561 · Supplement to a New Drug Submission (SNDS)
- TWYNEODecember 4, 2025 · NOC 36482 · New Drug Submission (NDS)
- FAMVIRSeptember 26, 2025 · NOC 36082 · Supplement to a New Drug Submission (SNDS)
- NEULEPTILSeptember 19, 2025 · NOC 36035 · Supplement to a New Drug Submission (SNDS)
- EPSOLAYAugust 27, 2025 · NOC 35909 · New Drug Submission (NDS)
- ANAPROX; ANAPROX DSJune 25, 2025 · NOC 35578 · New Drug Submission (NDS)
- ENABLEXJune 4, 2025 · NOC 35461 · Supplement to a New Drug Submission (SNDS)
- NAPROSYNApril 24, 2025 · NOC 35248 · New Drug Submission (NDS)
- DIPENTUMApril 8, 2025 · NOC 35141 · New Drug Submission (NDS)
- HALOETTEApril 1, 2025 · NOC 35094 · Supplement to an Abbreviated New Drug Submission (SANDS)
- FAMVIRFebruary 13, 2025 · NOC 34837 · New Drug Submission (NDS)
- NEXTSTELLISFebruary 11, 2025 · NOC 34821 · Supplement to a New Drug Submission (SNDS)
- NEXTSTELLISDecember 20, 2024 · NOC 34593 · Supplement to a New Drug Submission (SNDS)
- CEREBYXDecember 20, 2024 · NOC 34600 · Supplement to a New Drug Submission (SNDS)
- EVRADecember 9, 2024 · NOC 34512 · Supplement to a New Drug Submission (SNDS)
- DIVIGELOctober 16, 2024 · NOC 34212 · Supplement to a New Drug Submission (SNDS)
- ZESTORETICAugust 16, 2024 · NOC 33823 · Supplement to a New Drug Submission (SNDS)
- TENORMINJuly 18, 2024 · NOC 33671 · Supplement to a New Drug Submission (SNDS)
- ADDYIJuly 3, 2024 · NOC 33554 · Supplement to a New Drug Submission (SNDS)
- NORLUTATEApril 5, 2024 · NOC 33016 · Supplement to a New Drug Submission (SNDS)
- ATARAXMarch 19, 2024 · NOC 32910 · Supplement to a New Drug Submission (SNDS)
- VANCOCINFebruary 15, 2024 · NOC 32751 · Supplement to a New Drug Submission (SNDS)
- ZESTRILNovember 24, 2023 · NOC 32173 · Supplement to a New Drug Submission (SNDS)
- ZESTORETICNovember 17, 2023 · NOC 32126 · Supplement to a New Drug Submission (SNDS)
- PROCAN SRJune 29, 2023 · NOC 31118 · New Drug Submission (NDS)
- TENORMINJune 2, 2023 · NOC 30912 · Supplement to a New Drug Submission (SNDS)
- VALIUMMay 29, 2023 · NOC 30844 · New Drug Submission (NDS)
- NAVANEMay 24, 2023 · NOC 30813 · New Drug Submission (NDS)
- KETALARMay 24, 2023 · NOC 30819 · New Drug Submission (NDS)
- NEULEPTILJanuary 27, 2023 · NOC 29995 · New Drug Submission (NDS)
- ARLIDINJanuary 27, 2023 · NOC 29998 · New Drug Submission (NDS)
- AMSA PDOctober 26, 2022 · NOC 29305 · New Drug Submission (NDS)
- MANDELAMINEOctober 26, 2022 · NOC 29306 · New Drug Submission (NDS)
- MAJEPTILOctober 26, 2022 · NOC 29315 · New Drug Submission (NDS)
- PANECTYLOctober 20, 2022 · NOC 29244 · New Drug Submission (NDS)
- CHLOROMYCETIN SUCCINATE INJECTIONOctober 20, 2022 · NOC 29245 · New Drug Submission (NDS)
- CHOLEDYLOctober 20, 2022 · NOC 29266 · New Drug Submission (NDS)
- ERFA-TRANEXAMICOctober 19, 2022 · NOC 29253 · New Drug Submission (NDS)
- ATARAXOctober 14, 2022 · NOC 29201 · New Drug Submission (NDS)
- ERFA-AMIKACINOctober 14, 2022 · NOC 29202 · Abbreviated New Drug Submission (ANDS)
- CERUBIDINEOctober 14, 2022 · NOC 29203 · New Drug Submission (NDS)
- NORLUTATEOctober 14, 2022 · NOC 29208 · New Drug Submission (NDS)
- PARSITAN 50October 14, 2022 · NOC 29214 · New Drug Submission (NDS)
- CEREBYXOctober 7, 2022 · NOC 29166 · New Drug Submission (NDS)
- NARDILOctober 4, 2022 · NOC 29138 · New Drug Submission (NDS)
- LITHANESeptember 22, 2022 · NOC 29073 · New Drug Submission (NDS)
- EVRAApril 29, 2022 · NOC 28045 · New Drug Submission (NDS)
- HALOETTESeptember 8, 2021 · NOC 26608 · Abbreviated New Drug Submission (ANDS)
- ZESTORETICAugust 12, 2021 · NOC 26445 · Supplement to a New Drug Submission (SNDS)
- TENORMINJuly 30, 2021 · NOC 26369 · New Drug Submission (NDS)
- ZESTRILJuly 30, 2021 · NOC 26370 · New Drug Submission (NDS)
- ZESTORETICJuly 21, 2021 · NOC 26310 · New Drug Submission (NDS)
- NEXTSTELLISMarch 5, 2021 · NOC 25353 · New Drug Submission (NDS)
- ADDYIJanuary 27, 2021 · NOC 25080 · Supplement to a New Drug Submission (SNDS)
- ROCALTROLJanuary 27, 2021 · NOC 25094 · New Drug Submission (NDS)
- CHOLEDYL EXPECTORANTOctober 20, 2020 · NOC 29250 · New Drug Submission (NDS)
- ADDYIOctober 2, 2020 · NOC 24380 · New Drug Submission (NDS)
- ENABLEXMay 29, 2020 · NOC 23711 · Supplement to a New Drug Submission (SNDS)
- ENABLEXAugust 22, 2019 · NOC 22574 · Supplement to a New Drug Submission (SNDS)
- ENABLEXMarch 25, 2019 · NOC 22003 · Supplement to a New Drug Submission (SNDS)
- DIVIGELMarch 15, 2019 · NOC 21974 · Supplement to a New Drug Submission (SNDS)
- ENABLEXFebruary 11, 2019 · NOC 21842 · New Drug Submission (NDS)
- VANCOCINJanuary 21, 2019 · NOC 21778 · New Drug Submission (NDS)
- DIVIGEL (0.5 MG PACK); DIVIGEL (1 MG PACK); DIVIGEL(0.25 MG PACK)November 29, 2018 · NOC 21593 · New Drug Submission (NDS)
- ESTRAGYN VAGINAL CREAMJuly 25, 2018 · NOC 21140 · Supplement to a New Drug Submission (SNDS)
- PREFESTASeptember 2, 2016 · NOC 18472 · Supplement to a New Drug Submission (SNDS)
- OESCLIMAugust 26, 2016 · NOC 18413 · Supplement to a New Drug Submission (SNDS)
- ESTRAGYN VAGINAL CREAMAugust 19, 2016 · NOC 18394 · Supplement to a New Drug Submission (SNDS)
- ESTRAGYN VAGINAL CREAMNovember 24, 2015 · NOC 17514 · Supplement to a New Drug Submission (SNDS)
- ESTRAGYNJune 1, 2015 · NOC 16955 · New Drug Submission (NDS)
- ESTRAGYN VAGINAL CREAMJune 1, 2015 · NOC 16956 · New Drug Submission (NDS)
- PREFESTAJune 1, 2015 · NOC 16957 · New Drug Submission (NDS)
- OESCLIMMay 28, 2015 · NOC 16949 · New Drug Submission (NDS)
Recalls and safety alerts that mention its products
Health Canada’s recall notices do not carry licence numbers, so these are matched by name. A notice may cover another product or only some lots: read it to see what it covers.
- NARDIL (phenelzine sulfate) ShortageJune 24, 2020 · Drugs · Product safety
- Erfa-Tranexamic 100 mg/mL (5 ml)May 3, 2018 · Drugs · Product safety · Type I
- Erfa-Tranexamic 100 mg/mL (50mL)April 25, 2018 · Drugs · Product safety · Type I
- Information Update - Epilepsy drug Zarontin: Defective softgel capsules may reduce drug's effectivenessSeptember 22, 2016 · Drugs · Product safety
- Zarontin (ethosuximide) - Defective Capsules Associated with Reduced Efficacy (Increased Frequency of Seizures)September 22, 2016 · Drugs · Product safety
- ATARAX (hydroxyzine) - Risk of QT Prolongation and Torsade de PointesJune 6, 2016 · Drugs